Decibel Rising: Startup Tackles Inner-Ear Indications, Including Drug-Implant Combinations
This article was originally published in The Gray Sheet
The newly launched pharma startup Decibel Therapeutics wants to become the definitive inner-ear specialist, including combining its know-how with cochlear implant makers to improve that treatment and perhaps allow those devices to be miniaturized and be made more broadly applicable.
You may also be interested in...
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.
The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications.